Literature DB >> 27314491

Detection and Genomic Characterization of Senecavirus A, Ohio, USA, 2015.

Leyi Wang, Melanie Prarat, Jeff Hayes, Yan Zhang.   

Abstract

Entities:  

Keywords:  Ohio; SVA; Senecavirus A; United States; detection; genomic characterization; idiopathic vesicular disease; viruses

Mesh:

Year:  2016        PMID: 27314491      PMCID: PMC4918170          DOI: 10.3201/eid2207.151897

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Senecavirus A (SVA), formerly Seneca Valley virus, is a single-stranded positive-sense, nonenveloped RNA virus (). The RNA genome of SVA is 7.2 kb long and is translated into a polyprotein in a host cell. The polyprotein is then posttranslationally cleaved into mature proteins, including 4 structural viral capsid proteins (VP 1–4) in the N terminus and 7 nonstructural proteins (2A, 2B, 2C, 3A, 3B, 3Cpro, and 3Dpol) in the C terminus (). SVA was discovered as a contaminant of PER.C6 cells and is closely related to viruses in the genus Cardiovirus (). Genomic characterization has led to classification of SVA in a new genus, Senecavirus, family Picornaviridae. A retrospective study conducted in the United States showed that the samples collected during 1988–2001 were SVA positive, and genetic analysis revealed that the sequences of all 7 SVA isolates are considerably similar to the first US SVA strain (SVV-001), suggesting that SVA may have been circulating in the US pig population for a long time (). Idiopathic vesicular disease (IVD) is a vesicular disease of pigs, and etiology is unknown (). The clinical signs of IVD are fever, lameness, and vesicular lesions on various body parts including the oral cavity, snout, and coronary bands (). Despite not being a debilitating disease, IVD is noteworthy because it causes lesions clinically indistinguishable from those of other vesicular animal diseases, including foot-and-mouth disease (FMD), vesicular stomatitis, swine vesicular disease, and vesicular exanthema of swine. IVD has been reported in several countries, including the United States (–), and has been recognized in several US states, including Florida, Indiana, and Iowa (,,). Several lines of evidence show that SVA may be associated with IVD outbreaks in Canada, the United States, and Brazil (,,). We describe the detection and genomic characterization of SVA isolated from pigs with vesicular lesions in Ohio. In October 2015, the Animal Disease Diagnostic Laboratory of the Ohio Department of Agriculture received vesicle tissue, a vesicle swab sample, and whole blood from a sow with vesicular disease for rule-out testing for FMD virus (FMDV). The sow was lame on both front feet and had ruptured vesicular lesions on the snout and coronary bands of both front feet (Technical Appendix Figure). FMDV-specific real-time reverse transcription PCR was applied to the nucleic acid samples extracted from the 3 samples by using a MagMAX Pathogen RNA/DNA kit (Life Technologies, Carlsbad, CA, USA). All samples were negative for FMDV. We then performed 2 conventional reverse transcription PCRs with primers targeting 2 regions of the SVA genome (VP3/VP1, 3D/3′ untranslated region) on the same set of samples; the vesicle tissue and swab samples were SVA positive. Subsequently, we determined the whole-genome sequence of SVA by using 7 pairs of SVA–specific primers (Technical Appendix Table 1). We completed sequencing the whole genomes for the vesicle tissue (SVA-OH1) and vesicle swab sample (SVA-OH2). On the basis of BLAST (http:blast.ncbi.nlm.nih.gov/Blast.cgi) searches, the SVA-OH1 and -OH2 isolates had 99% nt identity to 3 new US strains (USA/IA40380/2015, USA/SD41901/2015, USA/IA46008/2015) and 98% nt identity to 3 Brazil strains (SVV/BRA/MG1/2015, SVV/BRA/MG2/2015, SVV/BRA/GO3/2015) from GenBank. The Ohio isolates also shared 96% and 94% nt identity with a Canada strain (11-55910-3) and the first US SVA strain (SVV-001), respectively. Further analysis showed that, in comparison with these 8 strains with complete genome sequences available in GenBank, the 2 Ohio SVA isolates had 22 unique nucleotide mutations in the genome: 1 in the VP4 gene, 5 in VP2, 2 in VP3, 1 in VP1, 4 in 2B, 3 in 2C, 3 in 3A, 1 in 3B, and 2 in 3D (Technical Appendix Table 2). Among the 22 unique mutations, there were 2 nonsynonymous mutations at position 2082 in the VP3 gene of both isolates and position 5037 in the 3A gene of SVA-OH1 and 1 unique synonymous mutation only in SVA-OH2. Phylogenetic analysis of the complete genome further supports that the 2 Ohio SVA isolates are closely related to each other and clustered together with the 3 recently isolated US strains, were less closely related to the isolates of the Brazil cluster, and were more distantly related to the isolate from Canada and the original SVA strain reported from United States (Figure). Consistent with the previous findings (), all SVA isolates from different countries clustered together under the genus Senecavirus, which is most closely related to the genus Cardiovirus of the family Picornaviridae (Figure). Our findings that a pig with clinical signs of IVD was infected with SVA and our genetic analysis demonstrating that the 2 Ohio SVA isolates are closely related to the other SVA strains from different countries provide further support for SVA involvement in IVD in pigs. More support could be provided by future studies, including continued surveillance of SVA and confirmation of the Koch postulates. Phylogenetic trees constructed on the basis of the whole-genome sequences of isolates from the genera Senecavirus (SVA), Cardiovirus, Teschovirus, and Enterovirus of the family Picornaviridae, including the SVA-OH1 and -OH2 isolates (black squares) from pigs in Ohio, USA. Dendrograms were constructed by using the neighbor-joining method in MEGA version 6.05 (http://www.megasoftware.net). Bootstrap resampling (1,000 replications) was performed, and bootstrap values are indicated for each node. Reference sequences obtained from GenBank are indicated by strain name and accession number. Scale bars indicate nucleotide substitutions per site.

Technical Appendix

Primers used for amplification and sequencing of the Senecavirus A complete genome, summary of unique mutations in SVA strains, and photographs of a sow with idiopathic vesicular disease.
  6 in total

1.  Idiopathic vesicular disease in swine in Manitoba.

Authors:  Tim Pasma; Suzanne Davidson; Sheryl L Shaw
Journal:  Can Vet J       Date:  2008-01       Impact factor: 1.008

2.  Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus.

Authors:  Laura M Hales; Nick J Knowles; P Seshidar Reddy; Ling Xu; Carl Hay; Paul L Hallenbeck
Journal:  J Gen Virol       Date:  2008-05       Impact factor: 3.891

3.  Vesicular lesions in swine - possible association with the feeding of marine products.

Authors:  B L Munday; F B Ryan
Journal:  Aust Vet J       Date:  1982-12       Impact factor: 1.281

4.  Parvovirus infection in pigs with necrotic and vesicle-like lesions.

Authors:  J I Kresse; W D Taylor; W W Stewart; K A Eernisse
Journal:  Vet Microbiol       Date:  1985-12       Impact factor: 3.293

5.  A vesiculo-bullous disease in pigs resembling foot and mouth disease. I. Field cases.

Authors:  J F Montgomery; R E Oliver; W S Poole
Journal:  N Z Vet J       Date:  1987-03       Impact factor: 1.628

6.  Identification and Complete Genome of Seneca Valley Virus in Vesicular Fluid and Sera of Pigs Affected with Idiopathic Vesicular Disease, Brazil.

Authors:  F A Vannucci; D C L Linhares; D E S N Barcellos; H C Lam; J Collins; D Marthaler
Journal:  Transbound Emerg Dis       Date:  2015-09-07       Impact factor: 5.005

  6 in total
  8 in total

1.  Pathogenicity of Seneca Valley virus in pigs and detection in Culicoides from an infected pig farm.

Authors:  Jinyong Zhang; Chenghui Li; Yuan Meng; Yubiao Xie; Ning Shi; He Zhang; Chengdong Yu; Fulong Nan; Changzhan Xie; Zhuo Ha; Jicheng Han; Zhuoxin Li; Qiuxuan Li; Peng Wang; Xu Gao; Ningyi Jin; Huijun Lu
Journal:  Virol J       Date:  2021-10-21       Impact factor: 4.099

2.  Senecavirus a 3D Interacts with NLRP3 to Induce IL-1β Production by Activating NF-κB and Ion Channel Signals.

Authors:  Sk Mohiuddin Choudhury; XuSheng Ma; ZongBo Zeng; Zhikuan Luo; Yuanyuan Li; XiaoFeng Nian; YongHua Ma; Zhengwang Shi; Rui Song; ZiXiang Zhu; Weijun Cao; Jingjing Pei; HaiXue Zheng
Journal:  Microbiol Spectr       Date:  2022-03-07

3.  Seneca Valley Virus 3Cpro Mediates Cleavage and Redistribution of Nucleolin To Facilitate Viral Replication.

Authors:  Jiangwei Song; Rong Quan; Dan Wang; Jue Liu
Journal:  Microbiol Spectr       Date:  2022-03-31

Review 4.  A Review on Pathological and Diagnostic Aspects of Emerging Viruses-Senecavirus A, Torque teno sus virus and Linda Virus-In Swine.

Authors:  Salwa Hawko; Giovanni P Burrai; Marta Polinas; Pier Paolo Angioi; Silvia Dei Giudici; Annalisa Oggiano; Alberto Alberti; Chadi Hosri; Elisabetta Antuofermo
Journal:  Vet Sci       Date:  2022-09-10

5.  Comprehensive phylogeographic and phylodynamic analyses of global Senecavirus A.

Authors:  Han Gao; Yong-Jie Chen; Xiu-Qiong Xu; Zhi-Ying Xu; Si-Jia Xu; Jia-Bao Xing; Jing Liu; Yun-Feng Zha; Yan-Kuo Sun; Gui-Hong Zhang
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

Review 6.  Update on Senecavirus Infection in Pigs.

Authors:  Raquel A Leme; Alice F Alfieri; Amauri A Alfieri
Journal:  Viruses       Date:  2017-07-03       Impact factor: 5.048

Review 7.  Review of Seneca Valley Virus: A Call for Increased Surveillance and Research.

Authors:  Xiangle Zhang; Zixiang Zhu; Fan Yang; Weijun Cao; Hong Tian; Keshan Zhang; Haixue Zheng; Xiangtao Liu
Journal:  Front Microbiol       Date:  2018-05-11       Impact factor: 5.640

8.  Dexamethasone treatment did not exacerbate Seneca Valley virus infection in nursery-age pigs.

Authors:  Alexandra Buckley; Nestor Montiel; Baoqing Guo; Vikas Kulshreshtha; Albert van Geelen; Hai Hoang; Christopher Rademacher; Kyoung-Jin Yoon; Kelly Lager
Journal:  BMC Vet Res       Date:  2018-11-20       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.